• KARM
  • Contact us
  • E-Submission
ABOUT
ARTICLE TYPES
BROWSE ARTICLES
AUTHOR INFORMATION

Articles

Original Article

Comparing the Values of Tissue Fluid Accumulation Using Tissue Dielectric Constant and Bioimpedance Analysis in Healthy Volunteers

Min Kyung Park, MD1orcid, Chang Hyun Lee, MD1orcid, Su-Hong Choi, PT, PhD1orcid, In Joo Kong, OT, MEd2orcid, Jin A Yoon, MD, PhD3orcid
Annals of Rehabilitation Medicine 2026;50(4):330-338.
Published online: August 12, 2026

1Department of Rehabilitation Medicine, Pusan National University Hospital, Busan, Korea

2Department of Rehabilitation Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, Korea

3Department of Rehabilitation Medicine, Pusan National University Hospital, Pusan National University School of Medicine and Biomedical Research Institute, Busan, Korea

Corresponding author: Jin A Yoon Department of Rehabilitation Medicine, Pusan National University Hospital, Pusan National University School of Medicine and Biomedical Research Institute, 179 Gudeok-ro, Seo-gu, Busan 49241, Korea. Tel: +82-51-240-7485 Fax: +82-51-247-7484 E-mail: yjk5289@naver.com
• Received: October 23, 2025   • Revised: June 3, 2026   • Accepted: July 6, 2026

© 2026 by Korean Academy of Rehabilitation Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 1,266 Views
  • 33 Download
prev next
  • Objective
    To quantitatively assess short-term, intervention-associated changes in tissue water distribution using tissue dielectric constant (TDC) and bioimpedance analysis (BIA) in healthy volunteers, and to explore correlations between the two modalities.
  • Methods
    Thirty-one healthy participants underwent a lymphedema-related intervention on their dominant arm, which included pumping and clearing of the terminus, manual lymphatic drainage, and low-level laser therapy. TDC and BIA were measured before and after the intervention. TDC-derived percentage of water content (PWC) was obtained at nine anatomical sites using a Lymphscanner, while BIA was performed using an InBody S10. Pre- and post-intervention differences were analyzed, and correlations between ΔTDC and ΔBIA parameters were evaluated using Spearman’s correlation coefficients.
  • Results
    TDC showed small, site-dependent superficial water changes, with significant decreases in PWC at the trunk and breast, and a mild increase at the shoulder on the intervention side. BIA revealed significant increases in R0 and impedance at several frequencies, while extracellular water to total body water ratio and reactance remained unchanged. Correlation analyses identified a few site-specific significant associations between ΔTDC and ΔBIA parameters; however, these correlations were weak-to-moderate and exhibited no consistent pattern across sites or frequencies.
  • Conclusion
    Although TDC and BIA both detected small intervention-associated changes in healthy volunteers, the limited correlations between the two modalities suggest that they are not interchangeable. TDC reflects localized superficial tissue water, whereas BIA assesses broader segmental fluid distribution. Therefore, their combined use may provide complementary information by evaluating distinct aspects of tissue water distribution. Further studies involving patients with lymphedema are warranted.
Lymphedema is a chronic and progressive condition characterized by protein-rich fluid accumulation in the interstitial tissue due to an imbalance between lymphatic fluid production and transport capacity. It often leads to chronic swelling, fibrosis, and functional impairment of the affected limb, thereby reducing quality of life [1,2].
Conservative management primarily involves complete decongestive physical therapy (CDPT), which includes manual lymphatic drainage (MLD), compression, exercise, and skin care and education [3,4]. Although CDPT is recognized as the standard intervention, current evidence regarding its efficacy and long-term benefits remains limited, emphasizing the need for accurate and objective assessment tools for both diagnosis and monitoring of treatment outcomes. Conventional methods, including limb circumference and volumetry, are limited in their sensitivity to detect subtle or region-specific fluid changes [5].
Among various measurement techniques, bioimpedance analysis (BIA) and tissue dielectric constant (TDC) measurements are quantitative methods that enable detection of extracellular fluid (ECF) retention and localized tissue water accumulation resulting from impaired lymphatic drainage [6-8]. BIA is an established method grounded on well-validated biophysical principles, providing accurate and reliable estimates of extracellular and intracellular fluid distribution and overall tissue fluid status by measuring tissue impedance in response to an alternating electrical current [9-11]. In contrast, TDC enables rapid and site-specific assessment of superficial tissue water by analyzing electromagnetic reflection from the skin surface [8,12]. Both techniques have demonstrated high sensitivity and reliability for the early detection of lymphedema and are currently used in clinical practice. Although each method reflects tissue water content, they assess different aspects of fluid distribution: BIA reflects segmental extracellular and intracellular fluid distribution, whereas TDC measures superficial tissue water at localized skin regions. To our knowledge, this is the first study to simultaneously apply both BIA and TDC measurements to investigate short-term fluid changes following lymphedema-related interventions. Therefore, this study aimed to evaluate pre- and post-intervention changes in tissue water content using TDC and BIA following a single treatment session in healthy individuals and to explore the correlations between the two modalities for future lymphedema research.
Participants
This study was a prospective, single-arm pre–post clinical study conducted at a tertiary hospital. Outcome assessors were blinded to the intervention, and outcome measures were evaluated before and after the intervention. Thirty-one healthy participants (12 males and 19 females, aged in their twenties to thirties) were recruited for the study. None of the participants were pregnant, or had a history of cancer, heart disease, renal failure, pulmonary hypertension, congenital lymphatic obstruction, or had conditions that may cause upper limb edema. All participants received information about the study and provided written informed consent before inclusion. The study protocol was approved by the Institutional Review Board (IRB) of Pusan National University Hospital (IRB No. 2308-023-130), and written informed consent was obtained from all participants.
Intervention protocol
All interventions were performed by one licensed physical therapist at a tertiary hospital who had completed standardized training in MLD. Each participant underwent a single standardized session on the dominant upper limb (i.e., the intervention side), consisting of pumping and clearing of the supraclavicular fossa for 5 minutes, a 5-minute rest period, MLD for 10 minutes, a second 5-minute rest period, and low-level laser therapy (LLLT) for 15 minutes (Fig. 1). LLLT was applied to the ipsilateral axillary lymph nodes, which are key drainage sites. Participants were positioned supine with the dominant arm externally rotated at 90°. LLLT was administered using the LTU-904 device (RianCorp.; a wavelength 904 nm). Fifteen points spaced 2 cm apart within the axillary region were irradiated for 1 minute each (total dose: 22.5 J/cm2). These parameters followed the manufacturer’s specifications and previously published safety-validated protocols [13].
Measurements
TDC and BIA measurements were obtained before and after the single session by one trained research examiner. To minimize inter-operator variability, the same examiner performed all assessments for all participants, following identical measurement procedures throughout the study.
TDC measurements were performed using a Lymphscanner device (Delfin Technologies). A handheld probe was placed on the skin for approximately 10 seconds at each of nine predetermined sites on both dominant and non-dominant arms, during which the device provided TDC values, expressed as percentage of water content (PWC), within a few seconds. Each site was measured three times, and the mean of the three readings was used for analysis.
BIA measurements were obtained using an InBody S10 device (InBody Co.). Standardized electrode placement and limb positioning recommended by the manufacturer were applied uniformly to all participants. The following standard output parameters provided by the device were analyzed for each arm: extracellular water to total body water ratio (ECW/TBW), impedance at frequencies of 1, 5, 50, 250, 500 kHz, and 1 MHz, reactance at 5, 50, and 250 kHz, extrapolated resistance at 0 Hz (R0) and segmental body water.
Statistical analysis
Data are expressed as mean±standard deviation or as number and percentage, where appropriate. Normality of all TDC and BIA variables (pre-, post-, and Δ values) was evaluated using the Shapiro–Wilk test. For variables that did not satisfy normality assumptions, Wilcoxon signed-rank tests were performed, and the results were used for the final statistical interpretation. Overall, these analyses showed similar directional trends to the paired t-test results.
Pre- and post-intervention values of TDC and BIA were compared between the intervention and non-intervention sides using paired t-tests or Wilcoxon signed-rank tests, as appropriate. Intervention-associated changes (Δ [post–pre]) were also compared between sides using the same methods.
To examine the correlation between localized changes in tissue water and segmental bioimpedance alterations following the intervention, Spearman’s rank correlation analyses were conducted using the Δ (post–pre) values of PWC (obtained from nine measurement sites) and corresponding BIA parameters on the intervention side. The correlation coefficients (ρ) were visualized as a heatmap.
A two-tailed p-value<0.05 was considered statistically significant. Paired t-tests were performed using IBM SPSS Statistics, version 28.0 (IBM Corp.), and correlation analyses with heatmap visualization were conducted using R software, version 4.5.0 (R Core Team, 2025; R Foundation for Statistical Computing; https://www.R-project.org/).
Thirty-one healthy adults (12 males and 19 females; mean age, 23.29±3.07 years; body mass index, 23.12±2.94 kg/m2) participated in the study (Table 1). The participants were neither obese nor exhibiting abnormal fluid retention at baseline.
Before the intervention, mean PWC values obtained from TDC measurements varied across the nine measurement sites on both the intervention and non-intervention sides (Table 2). PWC values were generally comparable between sides, except for a significant difference at the ventral side of forearm (p=0.017). After the intervention, PWC on the intervention side exhibited site-dependent changes. Significant decreases were observed at the trunk (p=0.048) and breast (p=0.002), while a mild increase was detected at the shoulder (p=0.009). On the non-intervention side, PWC showed slight increases at the ventral side of upper arm (p=0.048) and shoulder (p=0.011), but a decrease at the ventral side of forearm (p=0.022). Between-side comparison of Δ (post–pre) values revealed a significant difference only at the ventral side of forearm (p<0.001), reflecting a non-significant increase on the intervention side (p=0.053) and a significant decrease on the non-intervention side (p=0.022).
According to the BIA results, ECW/TBW showed no significant changes on either side after the intervention (Table 3). On the intervention side, R0 and impedance at 5, 250, 500 kHz, and 1 MHz increased significantly (p=0.011–0.047). On the non-intervention side, R0 and impedance values at all measured frequencies (1 kHz to 1 MHz) significantly increased (all p≤0.002). Reactance and ECW/TBW remained unchanged on both sides, whereas segmental body water slightly decreased on the non-intervention side (p=0.011). Between-side comparisons of Δ (post–pre) values revealed significant differences only in reactance at 250 kHz (p=0.008) and in segmental body water (p=0.006).
Spearman’s rank correlation analyses were performed between Δ (post–pre) values of PWC obtained from nine measurement sites on the intervention side (Table 2) and corresponding Δ (post–pre) values of BIA parameters on the same side (Table 3, Fig. 2). Significant but weak-to-moderate correlations were identified in a few site–parameter combinations. ΔPWC at the ventral side of forearm (ρ=-0.392, p=0.029) and dorsal side of forearm (ρ=-0.484, p=0.006) showed negative correlations with Δreactance at 250 kHz, whereas ΔPWC at the shoulder correlated negatively with Δimpedance at 1 kHz (ρ=-0.380, p=0.035). In contrast, ΔPWC at the breast demonstrated a weak positive correlation with Δreactance at 5 kHz (ρ=0.356, p=0.049). No consistent or strong correlations were observed across other sites or parameters.
This study quantitatively compared changes in tissue water distribution using TDC and BIA in healthy adults following a single standardized lymphedema-related intervention protocol. Both modalities detected intervention-associated alterations; however, the magnitude and spatial patterns of change differed according to the measurement principles and the tissue depths assessed. TDC primarily reflected localized, superficial changes in tissue water, whereas BIA captured segmental variations associated with ECF balance. TDC revealed site-dependent variations in superficial tissue water, with significant decreases in PWC observed at the trunk and breast, and a mild increase at the shoulder on the intervention side. These regional differences likely reflect transient redistribution of interstitial fluid induced by MLD and LLLT [14]. Such superficial changes may precede deeper fluid shifts and thus serve as sensitive indicators of early lymphatic response to therapy [15,16].
Because the participants were healthy individuals without lymphatic dysfunction, the magnitude of tissue water change was small and primarily limited to areas with relatively thicker subcutaneous tissue, such as the trunk and breast. This mild physiological response contrasts with the pathological fluid accumulation observed in lymphedema, where ECF is more pronounced, and intervention-associated changes are expected to be larger and clinically meaningful. Previous studies in patients with lymphedema have demonstrated reductions in tissue water ranging from approximately 8% to 17% using TDC measurements after a single session of MLD or LLLT, as well as ECW/TBW decreases of approximately -0.018 following decongestive treatment—magnitudes that clearly exceed those observed in the present healthy participants [17,18]. Accordingly, the small changes detected in our study fall well below the range previously reported in lymphedema populations and likely reflect the limited capacity for measurable fluid reduction in tissue without baseline fluid overload. From a measurement perspective, previous test–retest studies have reported site-dependent measurement errors and/or minimal detectable changes for TDC- or PWC-based measurements, as well as for limb-specific BIA measurements [19-21]. Given the limited availability of directly comparable thresholds for the present protocol and frequency-specific impedance parameters, the small statistically significant changes observed in this healthy cohort should be interpreted cautiously as subtle physiological responses rather than definitive clinically meaningful fluid reduction.
Compared to BIA, which provides segmental estimates of limb fluid but lacks regional resolution, TDC measurement allows rapid, site-specific assessment of superficial tissue water [6]. This advantage is particularly relevant when evaluating early or localized lymphedema that may not affect an entire limb segment. For instance, in breast cancer-related lymphedema, indocyanine-green lymphography has been used to map lymphatic drainage and guide individualized treatment, highlighting the importance of precise regional assessment [22,23]. Similarly, in radiation-induced lymphedema involving the head, neck, upper chest, and groin—areas where BIA cannot reliably measure segmental fluid distribution—TDC serves as a practical tool for localized quantitative evaluation [24].
BIA provided quantitative information on segmental fluid distribution and ECW status. Significant increases in R0 and impedance at 5, 250, 500 kHz, and 1 MHz were observed on the intervention side following the intervention, whereas ECW/TBW and reactance showed no meaningful changes. These findings are consistent with previous reports indicating that reductions in ECW are accompanied by increases in resistance, supporting the physiological validity of the present results [25]. Although impedance increases were observed on both sides, the patterns differed substantially. The non-intervention side exhibited broad, non-specific increases across nearly all measured frequencies, a pattern commonly associated with within-subject physiological or measurement-related variability rather than true ECF shifts. Bioimpedance measurements are influenced not only by fluid volume but also by conductive tissue properties such as skin temperature, peripheral circulation, and autonomic tone, which may result in small, time-dependent impedance fluctuations independent of localized intervention effects [9,11,26]. In contrast, the intervention side demonstrated selective changes at frequencies known to be sensitive to ECW, suggesting a mild and localized response to the intervention. While the magnitude of ΔBIA values was small, this is expected in healthy individuals with tightly regulated ECF balance. Nevertheless, Δ values remain informative because they remove baseline differences and help isolate subtle intervention-related changes.
Because this study involved healthy individuals without baseline fluid retention, large and clinically meaningful intervention-associated changes in tissue water were not expected. Rather than assessing therapeutic efficacy, the primary aim was to explore how simultaneously measured TDC and BIA parameters relate to each other under identical physiological and measurement conditions. To date, no study has directly compared localized superficial tissue water changes detected by TDC with segmental ECF estimates obtained from BIA within the same individuals.
Correlation analyses between ΔPWC and ΔBIA parameters demonstrated only weak and inconsistent associations across measurement sites and frequencies. ΔPWC at the forearm and shoulder correlated negatively with impedance or reactance, whereas a weak positive correlation was observed at the breast. The absence of strong or uniform correlations suggests that TDC and BIA capture different aspects of tissue water distribution—TDC reflecting localized superficial changes, and BIA representing segmental and deeper ECF balance. Therefore, these two modalities should be interpreted as complementary rather than interchangeable. As these correlations were identified in healthy individuals, further investigations in patients with clinically manifest lymphedema are warranted to elucidate their clinical significance and potential diagnostic value.
The combined use of TDC and BIA may provide a more comprehensive evaluation of tissue water dynamics by integrating localized and segmental perspectives. TDC enables rapid, site-specific evaluation of superficial tissue water, whereas BIA provides reliable quantitative information on systemic and compartmental fluid distribution. In addition, BIA primarily reflects overall changes in ECF across the affected limb, while TDC can also be applied to proximal regions—such as the trunk, breast, and perineal area—that are difficult to evaluate in detail by BIA, providing complementary information on intervention-associated tissue water changes. Together, these modalities enable a more integrated and detailed assessment of therapeutic outcomes. Their combined application may enhance the objectivity and sensitivity of lymphedema evaluation and support the development of individualized, evidence-based treatment strategies.
Despite these insights, this study has several limitations. First, it included only young, healthy adults; therefore, the results cannot be directly generalized to patient populations or used to establish cutoff values for lymphedema diagnosis. Nevertheless, as the first study to simultaneously assess TDC and BIA in the same participants, it provides valuable normative baseline data that can serve as a foundation for future research in patients.
Second, due to the absence of prior comparative studies, direct interpretation between TDC and specific BIA parameters remains limited. Because the two devices operate based on fundamentally different physical principles, each parameter should be interpreted within its own measurement context rather than directly compared.
Third, we did not perform baseline lymphatic imaging (e.g., lymphoscintigraphy or ICG lymphography) to objectively confirm lymphatic function in our participants. Although all individuals were clinically healthy without signs of edema or lymphedema, the absence of imaging limits assessment of interindividual variability in lymphatic drainage capacity.
In conclusion, both TDC and BIA were feasible quantitative tools for detecting small intervention-associated changes in tissue water in healthy volunteers. Although the correlations between the two modalities were weak, their combined use may provide complementary information on localized and systemic fluid distribution following lymphedema-related interventions. Further studies involving patients with lymphedema are warranted to validate these findings and determine their clinical applicability.

CONFLICTS OF INTEREST

Jin A Yoon is an Editorial Board member of Annals of Rehabilitation Medicine. The author did not engage in any part of the review and decision-making process for this manuscript. Otherwise, no potential conflict of interest relevant to this article was reported.

FUNDING INFORMATION

This work was supported by clinical research grant from Pusan National University Hospital in 2026.

AUTHOR CONTRIBUTION

Conceptualization: Yoon JA. Methodology: Yoon JA. Validation: Park MK. Formal analysis: Park MK, Lee CH. Funding acquisition: Yoon JA. Project administration: Yoon JA. Investigation: Kong IJ, Choi SH. Resources: Yoon JA. Data curation: Kong IJ, Lee CH. Visualization: Park MK. Supervision: Yoon JA. Writing – original draft: Park MK. Writing – review and editing: Lee CH, Choi SH, Kong IJ, Yoon JA. Approval of final manuscript: all authors.

Fig. 1.
Flowchart of the study protocol. Each participant received pumping and clearing of the terminus (5 minutes), manual lymphatic drainage (MLD, 10 minutes), and low-level laser therapy (LLLT, 15 minutes), with 5-minute rest intervals between procedures. Tissue dielectric constant (TDC) and bioimpedance analysis (BIA) measurements were performed before and after the intervention.
arm-250143f1.jpg
Fig. 2.
Spearman correlation heatmap between intervention-associated changes in tissue dielectric constant-derived percentage of water content (ΔPWC) at nine measurement sites and bioimpedance analysis (ΔBIA) parameters on the intervention side. Each cell represents Spearman’s rank correlation coefficient (ρ) between ΔPWC and ΔBIA parameters. Positive values indicate that an increase in PWC is associated with an increase in the corresponding BIA parameter. *p<0.05 and **p<0.01. ECW/TBW, extracellular water to total body water ratio.
arm-250143f2.jpg
arm-250143f3.jpg
Table 1.
Demographic characteristics of participants
Variable Total (n=31)
Sex (male/female) 12 (38.7)/19 (61.3)
Age (yr) 23.29±3.07
Height (cm) 167.90±8.33
Weight (kg) 65.56±12.02
Body mass index (kg/m2) 23.12±2.94
Percentage body fat (%) 25.39±9.27
Skeletal muscle mass (kg) 26.72±7.01
Fat-free mass (kg) 48.32±11.30
Total body water (TBW, kg) 35.38±8.25
Extracellular water (ECW, kg) 13.36±2.90
ECW/TBW 0.38±0.01

Values are presented as number (%) or mean±standard deviation.

Results: “The participants were neither obese nor exhibiting abnormal fluid retention at baseline.”

Table 2.
Pre- and post-intervention PWC at nine measurement sites on the intervention and non-intervention sides
Location Pre Post Δ (post–pre)
Intervention side Non-intervention side Between-side difference Intervention side Non-intervention side Between-side difference Intervention side Non-intervention side Between-side difference
Ventral side of forearm 41.17±6.76 42.34±6.41 -1.17±2.51 p=0.017* 41.94±6.27 41.72±6.22 0.22±3.02 p=0.202 0.76±1.85 p=0.053 -0.62±1.44 p=0.022* 1.39±1.86 p<0.001***
Medial side of upper arm 33.85±5.82 32.98±4.78 0.87±3.31 p=0.381 33.49±5.35 32.73±4.89 0.76±2.26 p=0.031* -0.35±1.91 p=0.836 -0.25±2.44 p=0.249 -0.11±3.18 p=0.814
Ventral side of upper arm 37.53±6.38 37.05±5.37 0.47±3.24 p=0.810 37.72±6.19 37.56±5.27 0.16±2.94 p=0.545 0.19±1.09 p=0.345 0.51±1.21 p=0.048* -0.31±1.82 p=0.477
Shoulder 43.35±5.30 43.37±5.20 -0.01±2.21 p=0.979 44.23±5.53 44.01±4.94 0.22±2.32 p=0.609 0.87±1.73 p=0.009** 0.65±1.32 p=0.011* 0.23±1.94 p=0.472
Hand 39.98±5.87 38.58±5.23 1.40±4.43 p=0.089 40.31±5.78 38.57±5.74 1.74±3.92 p=0.019* 0.33±2.81 p=0.514 -0.01±3.68 p=0.987 0.34±5.15 p=0.713
Dorsal side of forearm 43.95±6.29 43.10±6.02 0.85±4.44 p=0.295 44.12±6.41 43.30±5.66 0.82±3.99 p=0.263 0.17±2.96 p=0.748 0.20±2.56 p=0.666 -0.03±4.90 p=0.816
Dorsal side of upper arm 37.49±4.07 37.10±4.51 0.40±3.09 p=0.274 37.59±4.34 37.87±4.43 -0.28±3.87 p=0.690 0.10±2.58 p=0.835 0.77±2.42 p=0.068 -0.68±3.69 p=0.315
Trunk 42.40±5.71 41.83±4.98 0.57±3.50 p=0.371 40.92±5.23 41.57±4.51 -0.65±3.22 p=0.274 -1.47±3.98 p=0.048* -0.26±3.51 p=0.685 -1.22±4.65 p=0.156
Breast 46.44±3.47 46.22±3.01 0.23±2.21 p=0.574 45.11±2.70 45.57±3.07 -0.46±1.85 p=0.175 -1.33±2.18 p=0.002** -0.65±1.94 p=0.074 -0.69±2.71 p=0.167

Values are presented as mean±standard deviation.

Δ (post–pre) indicates the change after the intervention.

Between-sides difference was calculated as (intervention side - non-intervention side), and positive values indicate higher percentage of water content (PWC) on the intervention side.

Depending on the distribution of each variable, paired t-tests (for normally distributed data) or Wilcoxon signed-rank tests (for non-normally distributed data) were applied for within- and between-side comparisons.

*p<0.05,

**p<0.01, and

***p<0.001.

Table 3.
Pre- and post-intervention BIA parameters on the intervention and non-intervention sides
Parameter Pre Post Δ (post–pre)
Intervention side Non-intervention side Between-side difference Intervention side Non-intervention side Between-side difference Intervention side Non-intervention side Between-side difference
ECW/TBW 0.3760±0.0048 0.3779±0.0043 -0.0018±0.0024 p<0.001*** 0.3765±0.0049 0.3776±0.0040 -0.0011±0.0031 p=0.061 0.0004±0.0028 p=0.442 -0.0003±0.0026 p=0.365 0.0007±0.0037 p=0.204
R0 (Ω) 407.52±58.07 408.68±62.42 -1.16±12.90 p=0.616 414.91±63.71 418.68±63.96 -3.77±18.69 p=0.271 7.39±16.14 p=0.016* 10.00±16.01 p<0.001*** -2.61±19.21 p=0.096
Impedance (Ω) at 1 kHz 397.37±59.37 396.55±60.60 0.82±11.29 p=0.688 402.18±61.74 405.41±61.90 -3.23±13.60 p=0.164 4.80±13.78 p=0.062 8.86±13.26 p<0.001*** -4.05±15.71 p=0.161
Impedance (Ω) at 5 kHz 387.59±56.44 388.68±60.37 -1.09±10.12 p=0.480 393.34±60.71 397.40±60.47 -4.06±12.84 p=0.056 5.74±11.77 p=0.011* 8.72±11.66 p<0.001*** -2.97±13.24 p=0.221
Impedance (Ω) at 50 kHz 348.41±56.78 349.98±62.11 -1.57±11.72 p=0.461 352.11±60.62 357.46±60.06 -5.35±12.04 p=0.022* 3.71±12.24 p=0.102 7.48±12.55 p<0.001*** -3.77±14.01 p=0.144
Impedance (Ω) at 250 kHz 314.51±55.00 317.33±60.23 -2.82±11.54 p=0.167 318.02±58.18 324.17±58.81 -6.15±11.86 p=0.009** 3.51±11.56 p=0.047* 6.84±11.77 p=0.001** -3.33±14.28 p=0.204
Impedance (Ω) at 500 kHz 299.85±54.79 303.70±58.07 -3.86±9.56 p=0.052 304.29±56.19 310.49±56.73 -6.20±11.42 p=0.006** 4.45±9.25 p=0.018* 6.78±9.34 p=0.001** -2.34±12.73 p=0.315
Impedance (Ω) at 1 MHz 280.91±51.77 284.47±54.10 -3.57±9.09 p=0.039* 285.16±52.72 290.49±52.21 -5.32±10.35 p=0.006** 4.26±8.69 p=0.011* 6.01±8.69 p=0.002** -1.75±12.48 p=0.052
Reactance (Ω) at 5 kHz 16.05±3.68 15.83±1.99 0.22±3.04 p=0.691 16.49±2.34 16.25±2.47 0.24±1.67 p=0.438 0.44±2.85 p=0.402 0.42±2.55 p=0.799 0.02±3.35 p=0.439
Reactance (Ω) at 50 kHz 32.33±2.48 32.01±2.78 0.32±2.60 p=0.495 32.80±2.72 32.39±2.08 0.41±1.46 p=0.125 0.47±1.30 p=0.051 0.38±1.89 p=0.465 0.09±2.87 p=0.380
Reactance (Ω) at 250 kHz 33.79±4.22 34.21±5.47 -0.43±3.76 p=0.533 33.62±4.49 34.85±4.62 -1.24±3.58 p=0.063 -0.17±2.15 p=0.661 0.64±2.11 p=0.100 -0.81±1.60 p=0.008**
Segmental body water (L) 1.92±0.61 1.92±0.63 0.00±0.06 p=0.349 1.93±0.62 1.89±0.61 0.03±0.06 p=0.009** 0.01±0.07 p=0.926 -0.03±0.05 p=0.011* 0.03±0.08 p=0.006**

Values are presented as mean±standard deviation.

Extracellular water to total body water ratio (ECW/TBW) is dimensionless. Resistance at zero frequency (R0), impedance, and reactance are expressed in ohms (Ω), and segmental body water in liters (L).

Δ (post–pre) indicates the change after the intervention.

Between-sides difference was calculated as (intervention side - non-intervention side).

Depending on the distribution of each variable, paired t-tests (for normally distributed data) or Wilcoxon signed-rank tests (for non-normally distributed data) were applied for within- and between-side comparisons.

*p<0.05,

**p<0.01, and

***p<0.001.

  • 1. Manrique OJ, Bustos SS, Ciudad P, Adabi K, Chen WF, Forte AJ, et al. Overview of lymphedema for physicians and other clinicians: a review of fundamental concepts. Mayo Clin Proc 2022;97:1920-35.
  • 2. Grada AA, Phillips TJ. Lymphedema: pathophysiology and clinical manifestations. J Am Acad Dermatol 2017;77:1009-20.
  • 3. Gilchrist L, Levenhagen K, Davies CC, Koehler L. Effectiveness of complete decongestive therapy for upper extremity breast cancer-related lymphedema: a review of systematic reviews. Med Oncol 2024;41:297.
  • 4. Executive Committee. The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the International Society of Lymphology. Lymphology 2016;49:170-84.
  • 5. Rafn BS, Bodilsen A, von Heymann A, Lindberg MJ, Byllov S, Andreasen TG, et al. Examining the efficacy of treatments for arm lymphedema in breast cancer survivors: an overview of systematic reviews with meta-analyses. EClinicalMedicine 2024;67:102397.
  • 6. Lahtinen T, Seppälä J, Viren T, Johansson K. Experimental and analytical comparisons of Tissue Dielectric Constant (TDC) and Bioimpedance Spectroscopy (BIS) in assessment of early arm lymphedema in breast cancer patients after axillary surgery and radiotherapy. Lymphat Res Biol 2015;13:176-85.
  • 7. Kim L, Jeon JY, Sung IY, Jeong SY, Do JH, Kim HJ. Prediction of treatment outcome with bioimpedance measurements in breast cancer related lymphedema patients. Ann Rehabil Med 2011;35:687-93.
  • 8. Mayrovitz HN. Medical applications of skin tissue dielectric constant measurements. Cureus 2023;15:e50531.
  • 9. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, et al. Bioelectrical impedance analysis--part I: review of principles and methods. Clin Nutr 2004;23:1226-43.
  • 10. Lukaski HC. Evolution of bioimpedance: a circuitous journey from estimation of physiological function to assessment of body composition and a return to clinical research. Eur J Clin Nutr 2013;67 Suppl 1:S2-9.
  • 11. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gómez J, et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 2004;23:1430-53.
  • 12. Birkballe S, Jensen MR, Noerregaard S, Gottrup F, Karlsmark T. Can tissue dielectric constant measurement aid in differentiating lymphoedema from lipoedema in women with swollen legs? Br J Dermatol 2014;170:96-102.
  • 13. Kilmartin L, Denham T, Fu MR, Yu G, Kuo TT, Axelrod D, et al. Complementary low-level laser therapy for breast cancer-related lymphedema: a pilot, double-blind, randomized, placebo-controlled study. Lasers Med Sci 2020;35:95-105.
  • 14. Mayrovitz HN, Davey S. Changes in tissue water and indentation resistance of lymphedematous limbs accompanying low level laser therapy (LLLT) of fibrotic skin. Lymphology 2011;44:168-77.
  • 15. Mazor M, Smoot BJ, Mastick J, Mausisa G, Paul SM, Kober KM, et al. Assessment of local tissue water in the arms and trunk of breast cancer survivors with and without upper extremity lymphoedema. Clin Physiol Funct Imaging 2019;39:57-64.
  • 16. Tugral A, Viren T, Bakar Y. Tissue dielectric constant and circumference measurement in the follow-up of treatment-related changes in lower-limb lymphedema. Int Angiol 2018;37:26-31.
  • 17. Mayrovitz HN, Davey S, Shapiro E. Localized tissue water changes accompanying one manual lymphatic drainage (MLD) therapy session assessed by changes in tissue dielectric constant inpatients with lower extremity lymphedema. Lymphology 2008;41:87-92.
  • 18. Toshima M, Morino Y. Water distribution changes in complex decongestive treatment for leg lymphedema: quantitative evaluation by direct segmental multi-frequency bioimpedance analysis. Ann Vasc Dis 2022;15:94-100.
  • 19. Arends CR, van der Molen L, van den Brekel MWM, Stuiver MM. Test-retest reliability of a protocol for assessment of local tissue water in the head and neck area. Lymphat Res Biol 2024;22:12-9.
  • 20. Hagren A, Brogårdh C, Johansson K, Sjövall J, Ekvall Hansson E. Test-retest reliability of local tissue water and circumference measurements in the head and neck area of healthy women and men. Lymphat Res Biol 2023;21:381-7.
  • 21. Matsumoto C, Ishizaka M, Igawa T. Assessing limb-specific reliability in body composition: a study on minimal detectable change using bioimpedance analysis. J Phys Ther Sci 2025;37:181-5.
  • 22. Yoshida S, Koshima I, Imai H, Sasaki A, Fujioka Y, Nagamatsu S, et al. Indocyanine green lymphography findings in older patients with lower limb lymphedema. J Vasc Surg Venous Lymphat Disord 2020;8:251-8.
  • 23. Narushima M, Yamamoto T, Ogata F, Yoshimatsu H, Mihara M, Koshima I. Indocyanine green lymphography findings in limb lymphedema. J Reconstr Microsurg 2016;32:72-9.
  • 24. Mayrovitz HN, Patel A, Kavadi R, Khan Z, Bartolone S. An approach toward assessing head-and-neck lymphedema using tissue dielectric constant ratios: method and normal reference values. Lymphat Res Biol 2021;19:562-7.
  • 25. Rockson S. Bioimpedance analysis in the assessment of lymphoedema diagnosis and management. J Lymphoedema 2007;2:44-8.
  • 26. Gudivaka R, Schoeller DA, Kushner RF, Bolt MJ; New Collective Author. Single- and multifrequency models for bioelectrical impedance analysis of body water compartments. J Appl Physiol (1985) 1999;87:1087-96.

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      Download Citation

      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:

      Include:

      Comparing the Values of Tissue Fluid Accumulation Using Tissue Dielectric Constant and Bioimpedance Analysis in Healthy Volunteers
      Ann Rehabil Med. 2026;50(4):330-338.   Published online August 12, 2026
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Comparing the Values of Tissue Fluid Accumulation Using Tissue Dielectric Constant and Bioimpedance Analysis in Healthy Volunteers
      Ann Rehabil Med. 2026;50(4):330-338.   Published online August 12, 2026
      Close

      Figure

      • 0
      • 1
      • 2
      Comparing the Values of Tissue Fluid Accumulation Using Tissue Dielectric Constant and Bioimpedance Analysis in Healthy Volunteers
      Image Image Image
      Fig. 1. Flowchart of the study protocol. Each participant received pumping and clearing of the terminus (5 minutes), manual lymphatic drainage (MLD, 10 minutes), and low-level laser therapy (LLLT, 15 minutes), with 5-minute rest intervals between procedures. Tissue dielectric constant (TDC) and bioimpedance analysis (BIA) measurements were performed before and after the intervention.
      Fig. 2. Spearman correlation heatmap between intervention-associated changes in tissue dielectric constant-derived percentage of water content (ΔPWC) at nine measurement sites and bioimpedance analysis (ΔBIA) parameters on the intervention side. Each cell represents Spearman’s rank correlation coefficient (ρ) between ΔPWC and ΔBIA parameters. Positive values indicate that an increase in PWC is associated with an increase in the corresponding BIA parameter. *p<0.05 and **p<0.01. ECW/TBW, extracellular water to total body water ratio.
      Graphical abstract
      Comparing the Values of Tissue Fluid Accumulation Using Tissue Dielectric Constant and Bioimpedance Analysis in Healthy Volunteers
      Variable Total (n=31)
      Sex (male/female) 12 (38.7)/19 (61.3)
      Age (yr) 23.29±3.07
      Height (cm) 167.90±8.33
      Weight (kg) 65.56±12.02
      Body mass index (kg/m2) 23.12±2.94
      Percentage body fat (%) 25.39±9.27
      Skeletal muscle mass (kg) 26.72±7.01
      Fat-free mass (kg) 48.32±11.30
      Total body water (TBW, kg) 35.38±8.25
      Extracellular water (ECW, kg) 13.36±2.90
      ECW/TBW 0.38±0.01
      Location Pre Post Δ (post–pre)
      Intervention side Non-intervention side Between-side difference Intervention side Non-intervention side Between-side difference Intervention side Non-intervention side Between-side difference
      Ventral side of forearm 41.17±6.76 42.34±6.41 -1.17±2.51 p=0.017* 41.94±6.27 41.72±6.22 0.22±3.02 p=0.202 0.76±1.85 p=0.053 -0.62±1.44 p=0.022* 1.39±1.86 p<0.001***
      Medial side of upper arm 33.85±5.82 32.98±4.78 0.87±3.31 p=0.381 33.49±5.35 32.73±4.89 0.76±2.26 p=0.031* -0.35±1.91 p=0.836 -0.25±2.44 p=0.249 -0.11±3.18 p=0.814
      Ventral side of upper arm 37.53±6.38 37.05±5.37 0.47±3.24 p=0.810 37.72±6.19 37.56±5.27 0.16±2.94 p=0.545 0.19±1.09 p=0.345 0.51±1.21 p=0.048* -0.31±1.82 p=0.477
      Shoulder 43.35±5.30 43.37±5.20 -0.01±2.21 p=0.979 44.23±5.53 44.01±4.94 0.22±2.32 p=0.609 0.87±1.73 p=0.009** 0.65±1.32 p=0.011* 0.23±1.94 p=0.472
      Hand 39.98±5.87 38.58±5.23 1.40±4.43 p=0.089 40.31±5.78 38.57±5.74 1.74±3.92 p=0.019* 0.33±2.81 p=0.514 -0.01±3.68 p=0.987 0.34±5.15 p=0.713
      Dorsal side of forearm 43.95±6.29 43.10±6.02 0.85±4.44 p=0.295 44.12±6.41 43.30±5.66 0.82±3.99 p=0.263 0.17±2.96 p=0.748 0.20±2.56 p=0.666 -0.03±4.90 p=0.816
      Dorsal side of upper arm 37.49±4.07 37.10±4.51 0.40±3.09 p=0.274 37.59±4.34 37.87±4.43 -0.28±3.87 p=0.690 0.10±2.58 p=0.835 0.77±2.42 p=0.068 -0.68±3.69 p=0.315
      Trunk 42.40±5.71 41.83±4.98 0.57±3.50 p=0.371 40.92±5.23 41.57±4.51 -0.65±3.22 p=0.274 -1.47±3.98 p=0.048* -0.26±3.51 p=0.685 -1.22±4.65 p=0.156
      Breast 46.44±3.47 46.22±3.01 0.23±2.21 p=0.574 45.11±2.70 45.57±3.07 -0.46±1.85 p=0.175 -1.33±2.18 p=0.002** -0.65±1.94 p=0.074 -0.69±2.71 p=0.167
      Parameter Pre Post Δ (post–pre)
      Intervention side Non-intervention side Between-side difference Intervention side Non-intervention side Between-side difference Intervention side Non-intervention side Between-side difference
      ECW/TBW 0.3760±0.0048 0.3779±0.0043 -0.0018±0.0024 p<0.001*** 0.3765±0.0049 0.3776±0.0040 -0.0011±0.0031 p=0.061 0.0004±0.0028 p=0.442 -0.0003±0.0026 p=0.365 0.0007±0.0037 p=0.204
      R0 (Ω) 407.52±58.07 408.68±62.42 -1.16±12.90 p=0.616 414.91±63.71 418.68±63.96 -3.77±18.69 p=0.271 7.39±16.14 p=0.016* 10.00±16.01 p<0.001*** -2.61±19.21 p=0.096
      Impedance (Ω) at 1 kHz 397.37±59.37 396.55±60.60 0.82±11.29 p=0.688 402.18±61.74 405.41±61.90 -3.23±13.60 p=0.164 4.80±13.78 p=0.062 8.86±13.26 p<0.001*** -4.05±15.71 p=0.161
      Impedance (Ω) at 5 kHz 387.59±56.44 388.68±60.37 -1.09±10.12 p=0.480 393.34±60.71 397.40±60.47 -4.06±12.84 p=0.056 5.74±11.77 p=0.011* 8.72±11.66 p<0.001*** -2.97±13.24 p=0.221
      Impedance (Ω) at 50 kHz 348.41±56.78 349.98±62.11 -1.57±11.72 p=0.461 352.11±60.62 357.46±60.06 -5.35±12.04 p=0.022* 3.71±12.24 p=0.102 7.48±12.55 p<0.001*** -3.77±14.01 p=0.144
      Impedance (Ω) at 250 kHz 314.51±55.00 317.33±60.23 -2.82±11.54 p=0.167 318.02±58.18 324.17±58.81 -6.15±11.86 p=0.009** 3.51±11.56 p=0.047* 6.84±11.77 p=0.001** -3.33±14.28 p=0.204
      Impedance (Ω) at 500 kHz 299.85±54.79 303.70±58.07 -3.86±9.56 p=0.052 304.29±56.19 310.49±56.73 -6.20±11.42 p=0.006** 4.45±9.25 p=0.018* 6.78±9.34 p=0.001** -2.34±12.73 p=0.315
      Impedance (Ω) at 1 MHz 280.91±51.77 284.47±54.10 -3.57±9.09 p=0.039* 285.16±52.72 290.49±52.21 -5.32±10.35 p=0.006** 4.26±8.69 p=0.011* 6.01±8.69 p=0.002** -1.75±12.48 p=0.052
      Reactance (Ω) at 5 kHz 16.05±3.68 15.83±1.99 0.22±3.04 p=0.691 16.49±2.34 16.25±2.47 0.24±1.67 p=0.438 0.44±2.85 p=0.402 0.42±2.55 p=0.799 0.02±3.35 p=0.439
      Reactance (Ω) at 50 kHz 32.33±2.48 32.01±2.78 0.32±2.60 p=0.495 32.80±2.72 32.39±2.08 0.41±1.46 p=0.125 0.47±1.30 p=0.051 0.38±1.89 p=0.465 0.09±2.87 p=0.380
      Reactance (Ω) at 250 kHz 33.79±4.22 34.21±5.47 -0.43±3.76 p=0.533 33.62±4.49 34.85±4.62 -1.24±3.58 p=0.063 -0.17±2.15 p=0.661 0.64±2.11 p=0.100 -0.81±1.60 p=0.008**
      Segmental body water (L) 1.92±0.61 1.92±0.63 0.00±0.06 p=0.349 1.93±0.62 1.89±0.61 0.03±0.06 p=0.009** 0.01±0.07 p=0.926 -0.03±0.05 p=0.011* 0.03±0.08 p=0.006**
      Table 1. Demographic characteristics of participants

      Values are presented as number (%) or mean±standard deviation.

      Results: “The participants were neither obese nor exhibiting abnormal fluid retention at baseline.”

      Table 2. Pre- and post-intervention PWC at nine measurement sites on the intervention and non-intervention sides

      Values are presented as mean±standard deviation.

      Δ (post–pre) indicates the change after the intervention.

      Between-sides difference was calculated as (intervention side - non-intervention side), and positive values indicate higher percentage of water content (PWC) on the intervention side.

      Depending on the distribution of each variable, paired t-tests (for normally distributed data) or Wilcoxon signed-rank tests (for non-normally distributed data) were applied for within- and between-side comparisons.

      p<0.05,

      p<0.01, and

      p<0.001.

      Table 3. Pre- and post-intervention BIA parameters on the intervention and non-intervention sides

      Values are presented as mean±standard deviation.

      Extracellular water to total body water ratio (ECW/TBW) is dimensionless. Resistance at zero frequency (R0), impedance, and reactance are expressed in ohms (Ω), and segmental body water in liters (L).

      Δ (post–pre) indicates the change after the intervention.

      Between-sides difference was calculated as (intervention side - non-intervention side).

      Depending on the distribution of each variable, paired t-tests (for normally distributed data) or Wilcoxon signed-rank tests (for non-normally distributed data) were applied for within- and between-side comparisons.

      p<0.05,

      p<0.01, and

      p<0.001.

      TOP